Francesca Barone
2022
In 2022, Francesca Barone earned a total compensation of $908.3K as Chief Scientific Officer at Candel Therapeutics, a 149% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,522 |
|---|---|
| Option Awards | $233,988 |
| Salary | $362,192 |
| Stock Awards | $155,400 |
| Other | $12,200 |
| Total | $908,302 |
Barone received $362.2K in salary, accounting for 40% of the total pay in 2022.
Barone also received $144.5K in non-equity incentive plan, $234K in option awards, $155.4K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Francesca Barone's compensation ranked 3,245th out of 5,760 executives tracked by ExecPay. In other words, Barone earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,245 out of 5,760 | 44th |
Division Manufacturing | 1,822 out of 3,136 | 42nd |
Major group Chemicals And Allied Products | 868 out of 1,422 | 39th |
Industry group Drugs | 812 out of 1,323 | 39th |
Industry Biological Products, Except Diagnostic Substances | 196 out of 291 | 33rd |
Source: SEC filing on May 23, 2023.
Barone's colleagues
We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2022.